Table I.
Clinical features | BOS (n=10) | Stable (n=10) |
---|---|---|
Mean recipient age at transplant, years | 49±12 | 54±8 |
Male sex | 5(50%) | 5(50%) |
Race | ||
White | 10(100) | 9(90) |
African-American | 0(0) | 1(10) |
End-stage lung disease | ||
Cystic fibrosis | 5(50) | 1(10) |
Idiopathic pulmonary fibrosis | 3(30) | 0(0) |
Chronic obstructive pulmonary disease | 1(10) | 7(70) |
Other | 1(10) | 2(20) |
HLA mismatch | ||
A | 1.5±0.5 | 1.4±0.5 |
B | 1.8±0.4 | 1.6±0.5 |
DR | 1.9±0.3 | 1.3±0.9 |
Bilateral LTx | 10(100) | 10(100) |
Mean time from LTx to sampling, months | 17.3±8.2 | 24.4±10.7 |
Mean time from LTx to BOS onset, months | 16.2±8.9 | N/A |
Values presented as n (%), unless otherwise noted.
Abbreviations: BOS: bronchiolitis obliterans syndrome, HLA, human leukocyte antigen; LTx, lung transplantation; N/A, not applicable.